Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Rapid generation of anti-idiotypic antibodies

Rapid generation of anti-idiotypic antibodies

US Patent 10150817 · Granted Dec 11, 2018

Estimated economic value: $476,459,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CXCR5 antibodies and compositions and uses thereof2024
Antibodies directed against T cell immunoglobulin and mucin protein 3 (TIM-3)2023
FcRn antibodies and methods of use thereof2023
Antibodies directed against T Cell immunoglobulin and mucin protein 3 (TIM-3)2022
FcRn antibodies and methods of use thereof2022
Antibodies directed against programmed death-1 (PD-1)2021
Anti-CXCR5 antibodies and compositions and uses thereof2020
Antibodies directed against lymphocyte activation gene 3 (LAG-3)2020
Antibodies directed against programmed death-1 (PD-1)2020
FcRn antibodies and methods of use thereof2020
Antibodies directed against T cell immunoglobulin and mucin protein 3 (TIM-3)2019
PD-1 binding proteins and methods of use thereof2019